All In MedTech

Device Trial Radar · NCT07914010

Reducing Exposure With Air Cleaners and Technology

Reducing Exposure With Air Cleaners and Technology (REACT) in At-Risk Communities

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Nov 17, 2026

Primary completion

Sep 2027

Study completion Sep 2027

Sponsor

Lead sponsor
University of California, BerkeleyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of California, San Francisco; California Air Resources Board; Brightline Defense Project
First posted
Nov 3, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Fine particulate matter (PM2.5) is a type of air pollution made up of extremely tiny particles that can harm our health. Because PM2.5 particles are so small, they can travel deep into the lungs when inhaled. Exposure to PM2.5 can worsen asthma, cause breathing problems, increase the risk of heart attacks, and lead to early death, especially for people with existing heart or lung conditions. In California's Bayview Hunters Point (BVHP), a San Francisco community already facing high levels of air pollution and health impacts, sources of PM2.5 include industrial activity, commuter traffic, heavy-duty diesel trucks, freight trains, and port and maritime activities. The Reducing Exposure with Air Cleaners and Technology (REACT) Study is a partnership between University of California (UC) Berkeley, UC San Francisco, and Brightline Defense. The goal is to see if air cleaners (also called air purifiers) can help reduce indoor PM2.5 levels and improve respiratory health. For this study, the investigators will be recruiting 100 households in BVHP to participate. In each home, indoor PM2.5 levels and the health status of household members who are 13 years old or older and have asthma or chronic obstructive pulmonary disease (COPD) will be monitored. Each home will be part of the study for 90 to 120 days, depending on scheduling. Households must reside in BVHP for the duration of the study and not have used an air cleaner in their home within the last 6 months. On Day 1, each household will receive a PurpleAir indoor air quality monitor to measure PM2.5 levels in their home. * For the first 30 days, the investigators will measure the home's normal air quality (baseline). * After 30 days, each household will receive an air cleaner with information about how to best use it. * At that point, a PM2.5 indicator light will be turned on for half of the PurpleAir monitors. For the other half, indicator light will be kept turned off. This helps the investigators study whether seeing the air quality in real time changes how people use the air cleaner. * For the next 30 days, indoor PM2.5 levels will continue to be monitored. How often the air cleaner is used will also be tracked with smart plug data loggers. * After 60 days, more training and support will be offered to all participants and monitoring will continue over the final 30 days of the study.

Conditions

  • Asthma
  • COPD (Chronic Obstructive Pulmonary Disease)

Interventions

  • Air CleanerDevice

    During Phase 2 of the study, an air cleaner will be installed in each participant's household. All participants will receive this device and intervention.

  • PM2.5 Monitor with Visual Air Quality IndicatorDevice

    To assess how visual input from a low-cost particulate matter monitor can increase the use and effectiveness of air cleaners, participants will be randomized to receive monitors with a visual indoor air quality indicator (Arm 1, intervention) and without a visual indoor air quality indicator (Arm 2, control). Participants will be randomized 1:1 using blocks into the intervention arm or control arm.

  • Educational MaterialsBehavioral

    All participants will receive educational materials about the PurpleAir monitor, air cleaner and its best use, and the Air Quality Index. For those in Arm 1, the second half of the Air Quality Index fact sheet will describe the visual air quality indicator on their PurpleAir monitor. For those in Arm 2, the second half of the fact sheet will share general information about where local air quality information can be found.

  • Air Cleaner Technical AssistanceBehavioral

    To evaluate how additional information and/or engagement can further impact air cleaner use and effectiveness, investigators will provide additional technical assistance on air cleaner usage in three different forms: (1) text messages that reinforce air cleaner use through reminders and tips and targets spatial barriers and in-the-moment behaviors; (2) short-form videos that show the participants how to use their air cleaner and share community member perspectives on benefits, safety concerns, and household dynamics; and (3) video calls with study staff to build skills and confidence and reinforce value of using the air cleaner. Participants will be randomized to receive one, two, or all three of these forms of air cleaner technical assistance.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Air Quality: Absolute Change in Daily Average Indoor Fine Particulate Matter (PM2.5) ConcentrationTime frame: Baseline (Days 1-30), initial intervention (Days 31-60), and targeted technical assistance (Days 61-90)
  2. Air Quality: Percent Change in Daily Average Indoor Fine Particulate Matter (PM2.5) ConcentrationTime frame: Baseline (Days 1-30), initial intervention (Days 31-60), and targeted technical assistance (Days 61-90)
  3. Difference in Self-Reported Respiratory Symptoms using Breathlessness, Cough, and Sputum Scale (BCSS) or Asthma Control Test (ACT)Time frame: Baseline (Days 1-30), initial intervention (Days 31-60), and targeted technical assistance (Days 61-90)

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • University of California, Berkeley

    Berkeley, California · Recruiting

  • Brightline Defense Project

    San Francisco, California · Recruiting

  • University of California, San Francisco

    San Francisco, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.